Tetany < Tetrabenazine < Tetracaine

Facettes :

List of bibliographic references indexed by Tetrabenazine

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
000586 (2014)	Nicolaas I. Bohnen [États-Unis] ; Kirk A. Frey [États-Unis] ; Stephanie Studenski [États-Unis] ; Vikas Kotagal [États-Unis] ; Robert A. Koeppe [États-Unis] ; Gregory M. Constantine [États-Unis] ; Peter J. H. Scott [États-Unis] ; Roger L. Albin [États-Unis] ; Martijn L. T. M Müller [États-Unis]	Extra-nigral pathologies are common in Parkinson disease with freezing of gait: an in vivo PET study
000638 (2014)	Silke Appel-Cresswell [Canada] ; Ali H. Rajput ; Vesna Sossi ; Christina Thompson ; Vanessa Silva ; Jessamyn Mckenzie ; Katherine Dinelle ; Siobhan E. Mccormick ; Carles Vilari O-Güell ; A Jon Stoessl ; Dennis W. Dickson ; Chris A. Robinson ; Matthew J. Farrer ; Alex Rajput	Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism.
000689 (2014)	Andre C. Felicio [Canada] ; Katherine Dinelle [Canada] ; Pankaj A. Agarwal [Canada] ; Jessamyn Mckenzie [Canada] ; Nicole Heffernan [Canada] ; Jeremy D. Road [Canada] ; Silke Appel-Cresswell [Canada] ; Zbigniew K. Wszolek [États-Unis] ; Matthew J. Farrer [Canada] ; Michael Schulzer [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada]	In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers
000B04 (2013)	Raja Mehanna [États-Unis] ; Christine Hunter ; Anthony Davidson ; Joohi Jimenez-Shahed ; Joseph Jankovic [États-Unis]	Analysis of CYP2D6 genotype and response to tetrabenazine.
000B50 (2012)	Martijn L. T. M. Müller [États-Unis] ; Kirk A. Frey [États-Unis] ; Myria Petrou [États-Unis] ; Vikas Kotagal [États-Unis] ; Robert A. Koeppe [États-Unis] ; Roger L. Albin [États-Unis] ; Nicolaas I. Bohnen [États-Unis]	β-amyloid and postural instability and gait difficulty in Parkinson disease at risk for dementia
001D32 (2010)	William G. Ondo [États-Unis] ; Octavian R. Adam [États-Unis] ; Joseph Jankovic [États-Unis] ; Patrick F. Chinnery [Royaume-Uni]	Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States
002007 (2009)	Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie]	Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
002B80 (2007)	Christopher Kenney [États-Unis] ; Christine Hunter [États-Unis] ; Anthony Davidson [États-Unis] ; Joseph Jankovic [États-Unis]	Short‐term effects of tetrabenazine on chorea associated with Huntington's disease
002D66 (2007)	Christopher Kenney [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis]	Long‐term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders
003152 (2006)	Samay Jain [États-Unis] ; Paul E. Greene [États-Unis] ; Steven J. Frucht [États-Unis]	Tetrabenazine therapy of pediatric hyperkinetic movement disorders
003153 (2006)	Oraporn Sitburana [États-Unis] ; William G. Ondo [États-Unis]	Tetrabenazine for hyperglycemic‐induced hemichorea–hemiballismus
003855 (2005)	Spiridon Papapetropoulos [États-Unis] ; Carlos Singer [États-Unis]	Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD)
003E27 (2004)	Stéphane Thobois [France] ; Jing Xie [France] ; Helena Mollion [France] ; Isabelle Benatru [France] ; Emmanuel Broussolle [France]	Adrafinil‐induced orofacial dyskinesia
003F17 (2003)	Anjan Chatterjee [États-Unis] ; Steven J. Frucht [États-Unis]	Tetrabenazine in the treatment of severe pediatric chorea
004789 (2001)	P. Shanahan [Irlande (pays)] ; M. Hutchinson [Irlande (pays)] ; A. Bohan [Irlande (pays)] ; D. O' Donoghue [Irlande (pays)] ; K. Sheahan [Irlande (pays)] ; A. Owens [Irlande (pays)]	Hemichorea, moya‐moya, and ulcerative colitis
004871 (2001)	A. Jon Stoessl [Canada]	Assessing the integrity of the dopamine system in Parkinson's disease: How best to do it?
004D19 (1999)	Nir Giladi [Israël] ; Eldad Melamed [Israël]	Levodopa therapy can ameliorate tetrabenazine‐induced parkinsonism
005246 (1997)	Elsdon Storey [Australie] ; John Lloyd [Australie]	Tardive tremor
005430 (1997)	Giselle M. Petzinger [États-Unis] ; Susan B. Bressman [États-Unis]	A case of tetrabenazine‐induced neuroleptic malignant syndrome after prolonged treatment
005569 (1996)	M. Ossemann [Belgique] ; C. J. M. Sindic [Belgique] ; C. Laterre [Belgique]	Tetrabenazine as a cause of neuroleptic malignant syndrome
005887 (1995)	Lagueny [France] ; P. Burbaud [France] ; G. Le Masson [France] ; F. X. Bergouignan [France] ; X. Ferrer [France] ; J. Julien [France]	Involvement of respiratory muscles in adult‐onset dystonia: A clinical and electrophysiological study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Tetrabenazine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Tetrabenazine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Tetrabenazine
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024